Agenus | AGEN - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 71.08M 11.9M 2026-03
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celldex Therapeutics USD 10.36M 9.18M 2026-03
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 10.46B 1.53B 2026-03
Jiangsu Hengrui CNY 2.33B 64.06M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.29M 500K 2026-03
Merck EUR 2.13B 19M 2026-03
Merck USD 3.86B 541M 2026-03
Northwest Biotherapeutics 36.72M 9.49M 2025-09
Novartis USD 4.32B 134M 2026-03
Novavax USD 16.1M 8.48M 2026-03
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 6.91M 2.32M 2026-03